Study directory

Mental health studies with practical context.

Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.

Back to overview
2022studies shown
Showing 1,301-1,325 of 2,022
CompletedNCT05537428

Song-making In a Group (SING) R61

This study exists to explore whether acceptance and commitment therapy, a talking treatment, could improve care and understanding. Researchers are trying to understand whether acceptance and commitment therapy, a talking treatment, can improve attention, thinking, or day-to-day functioning.

SchizophreniaOtherFrom 18 Years to 65 Years
Countries
United States
Sponsor
Yale University
Condition
Schizophrenia
CompletedNCT03183609

Confirmatory Efficacy Trial of a Gluten-Free Diet in a Subgroup of Persons With Schizophrenia Who Have High Levels of IgG Anti-Gliadin Antibodies (AGA IG)

This study exists to compare options and see whether blood tests and biological markers offers something meaningfully different. Researchers are trying to understand whether blood tests and biological markers can improve attention, thinking, or day-to-day functioning.

SchizophreniaOtherFrom 18 Years to 64 Years
Countries
United States
Sponsor
University of Maryland, Baltimore
Condition
Schizophrenia
CompletedNCT02848885

The Effects of tDCS on Illness Awareness in Schizophrenia

This study exists to explore whether brain scans or other body measurements could improve care and understanding. Researchers are trying to understand whether brain scans or other body measurements can improve attention, thinking, or day-to-day functioning.

SchizophreniaOtherOver 18 Years
Countries
Canada
Sponsor
Centre for Addiction and Mental Health
Condition
Schizophrenia
CompletedNCT05109065

Peripheral Immune System in Individuals With Schizophrenia

This study exists to learn from real-world information that can show how blood tests and biological markers fits into care. Researchers are trying to understand what blood tests and biological markers can reveal about signals in the brain or body that may guide care later on.

SchizophreniaOtherFrom 18 Years to 40 Years
Countries
United States
Sponsor
Stanford University
Condition
Schizophrenia
CompletedNCT07005388

Cultural Adaptation of Group CBT Psychosis Manual and Establishing Its Efficacy in Pakistan

This study exists to compare options and see whether cognitive behavioural therapy, a structured talking treatment, offers something meaningfully different. Researchers are trying to understand whether cognitive behavioural therapy, a structured talking treatment, can improve attention, thinking, or day-to-day functioning.

SchizophreniaOtherUp to 65 Years
Countries
Pakistan
Sponsor
Punjab Institute of Mental Health
Condition
Schizophrenia
CompletedNCT05643196

Focused Ultrasound Modulation of the Globus Pallidus Interna in Schizophrenia

This study exists to see whether a digital app or remote support tool is workable and worth testing more broadly. Researchers are trying to understand how people respond to a digital app or remote support tool in practice and what may need to be adjusted.

SchizophreniaOtherFrom 18 Years to 50 Years
Countries
United States
Sponsor
NYU Langone Health
Condition
Schizophrenia
CompletedNCT04430309

Baduanjin on Patients With Schizophrenia

This study exists to explore whether this type of care could improve care and understanding. Researchers are trying to understand whether this type of care can improve attention, thinking, or day-to-day functioning.

SchizophreniaOtherOver 40 Years
Countries
Taiwan
Sponsor
Chang Gung Memorial Hospital
Condition
Schizophrenia
CompletedNCT05686772

Prospective Multicenter Cohort Study Evaluating the Incidence and Risk Factors for Problem Gambling Among Young Adults With First-episode Psychosis

This study exists to understand what helps a digital app or remote support tool work in everyday practice, not just under ideal conditions. Researchers are trying to understand whether a digital app or remote support tool can work better when mental health difficulties overlap with substance use.

SchizophreniaOtherFrom 18 Years to 35 Years
Countries
Canada
Sponsor
Laval University
Condition
Schizophrenia
CompletedNCT03161249

Psychoeducative Treatment of FEP With Mobile Training. ThinkApp

This study exists to see whether psychoeducation, a guided learning and support program, can play a useful role in care. Researchers are trying to understand whether psychoeducation, a guided learning and support program, can improve attention, thinking, or day-to-day functioning.

SchizophreniaOtherFrom 14 Years to 30 Years
Countries
Spain
Sponsor
International University of La Rioja
Condition
Schizophrenia
Active Not RecruitingNCT06370793

Ningbo Schizophrenia Cohort

This study exists to understand how this type of care holds up over time after the earliest research stage. Researchers are trying to understand whether this type of care can better prevent setbacks and support longer-term stability.

SchizophreniaOtherFrom 18 Years to 65 Years
Countries
China
Sponsor
Ningbo University
Condition
Schizophrenia
CompletedNCT03526354

Controlled Trial of Brexpiprazole For The Treatment of Co-occurring Schizophrenia and Substance Use Disorder

This study exists to see whether the medication Brexpiprazole is workable and worth testing more broadly. Researchers are trying to understand whether the medication Brexpiprazole can work better when mental health difficulties overlap with substance use.

SchizophreniaOtherFrom 18 Years to 65 Years
Countries
United States
Sponsor
University of Massachusetts, Worcester
Condition
Schizophrenia
RecruitingNCT04629352

Effect of Neuroplasticity Modulation in tDCS Treatment Response Among Schizophrenia Patients With Auditory Hallucination

This study exists to see whether a digital app or remote support tool can play a useful role in care. Researchers are trying to understand what a digital app or remote support tool can reveal about signals in the brain or body that may guide care later on.

SchizophreniaOtherFrom 18 Years to 45 Years
Countries
India
Sponsor
National Institute of Mental Health and Neuro Sciences, India
Condition
Schizophrenia
RecruitingNCT06118268

iTBS to Enhance Social Cognition in People With Psychosis

This study exists to see whether a digital app or remote support tool can make care clearer and more responsive. Researchers are trying to understand whether a digital app or remote support tool can improve attention, thinking, or day-to-day functioning.

SchizophreniaOtherFrom 18 Years to 39 Years
Countries
United States
Sponsor
Northwell Health
Condition
Schizophrenia
RecruitingNCT06978803

HYEEG Discourse in Psychosis: A Neurobehavioural Study

This study exists to see whether questionnaires and follow-up reports can make care clearer and more responsive. Researchers are trying to understand whether questionnaires and follow-up reports can improve attention, thinking, or day-to-day functioning.

SchizophreniaOtherFrom 18 Years to 60 Years
Countries
Canada
Sponsor
Douglas Mental Health University Institute
Condition
Schizophrenia
Enrolling By InvitationNCT06978881

Magnetoencephalography in Psychosis Program

This study exists to see whether a digital app or remote support tool can make care clearer and more responsive. Researchers are trying to understand whether a digital app or remote support tool can improve attention, thinking, or day-to-day functioning.

SchizophreniaOtherFrom 18 Years to 50 Years
Countries
Canada
Sponsor
Douglas Mental Health University Institute
Condition
Schizophrenia
RecruitingNCT06345963

Enhancing Brain Connectivity in Schizophrenia Through Neuromodulation (Study 1)

This study exists to explore whether smoking support or smoking-related treatment could improve care and understanding. Researchers are trying to understand whether smoking support or smoking-related treatment can improve attention, thinking, or day-to-day functioning.

SchizophreniaOtherFrom 18 Years to 60 Years
Countries
United States
Sponsor
The University of Texas Health Science Center, Houston
Condition
Schizophrenia
RecruitingNCT06978894

Predicting Psychotic Relapse Using Speech-Based Early Detection

This study exists to understand how a digital app or remote support tool holds up over time after the earliest research stage. Researchers are trying to understand whether a digital app or remote support tool can improve attention, thinking, or day-to-day functioning.

SchizophreniaOtherOver 16 Years
Countries
Canada
Sponsor
Douglas Mental Health University Institute
Condition
Schizophrenia
Not Yet RecruitingNCT06974513

Auditory Localization in Schizophrenia

This study exists to see whether a digital app or remote support tool can make care clearer and more responsive. Researchers are trying to understand whether a digital app or remote support tool can improve attention, thinking, or day-to-day functioning.

SchizophreniaOtherFrom 18 Years to 35 Years
Countries
France
Sponsor
Hôpital le Vinatier
Condition
Schizophrenia
TerminatedNCT06972745

Efficacy & Tolerability of Rigth Unilateral vs. Bitemporal ECT in Schizophrenia in a Psychiatric Hospital in Mexico

This study exists to see whether a therapy or guided support program can make care clearer and more responsive. Researchers are trying to understand whether a therapy or guided support program can improve attention, thinking, or day-to-day functioning.

SchizophreniaOtherOver 18 Years
Countries
Mexico
Sponsor
Hospital Psiquiátrico Fray Bernardino Álvarez
Condition
Schizophrenia
CompletedNCT05486312

7-week Study With CT-155 in People With Schizophrenia

This study exists to see whether the medication CT-155 can play a useful role in care. Researchers are trying to understand whether the medication CT-155 can make support easier to access outside standard clinic visits.

SchizophreniaOtherFrom 18 Years to 64 Years
Countries
United States
Sponsor
Click Therapeutics, Inc.
Condition
Schizophrenia
TerminatedNCT03230097

This Study Tests Whether BI 409306 Prevents Patients With a Specific Type of Mental Illness (Attenuated Psychosis Syndrome) From Becoming Worse. This Study Looks at How Well Patients Tolerate the Medicine and How Effective it is Over 1 Year

This study exists to learn from real-world information that can show how questionnaires and follow-up reports fits into care. Researchers are trying to understand what questionnaires and follow-up reports could change in day-to-day care and decision-making.

SchizophreniaOtherFrom 16 Years to 30 Years
Countries
Canada, China, United Kingdom, United States
Sponsor
Boehringer Ingelheim
Condition
Schizophrenia